Protein and antibody engineering, recombinant therapeutic proteins, enzyme and biocatalyst engineering, SAR and molecular docking.

Fermentation and expression-system optimization, downstream purification, analytical platforms, scale-up and quality-by-design.

Nanoparticle, liposomal, polymeric, and lipid-nanoparticle delivery systems; bioconjugation; targeted and stimuli-responsive platforms.

Gene therapy vectors, oncolytic viruses, RNA-based therapeutics, cell-based and immunotherapy platforms.

Biomarker- and genotype-guided drug selection and dosing, drug repurposing with mechanistic rationale.

In vitro, in vivo, and early-phase clinical studies evaluating a biotechnological product, platform, or delivery system.